Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer cells. The Saudi Food and Drug Authority has become the first regulatory body globally to grant conditional approval for Anktiva in advanced non-small cell lung cancer and high-risk bladder cancer, offering a new treatment option for patients with limited a...
Receive updates from The Times of India - Middle East for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on Specificfeeds.
This way you won't miss any new article from The Times of India - Middle East. Unsubscribe at any time.
Site title: News: India News, Latest Bollywood News, Sports News, Business & Political News, National & International News | Times of India
